Home

The Korea Herald

Latest news

Most Popular

  1. 1

    Actor Jung Woo-sung admits to being father of model Moon Ga-bi’s child

    Actor Jung Woo-sung admits to being father of model Moon Ga-bi’s child
  2. 2

    Wealthy parents ditch Korean passports to get kids into international school

    Wealthy parents ditch Korean passports to get kids into international school
  3. 3

    Man convicted after binge eating to avoid military service

    Man convicted after binge eating to avoid military service
  4. 4

    First snow to fall in Seoul on Wednesday

    First snow to fall in Seoul on Wednesday
  5. 5

    Final push to forge UN treaty on plastic pollution set to begin in Busan

    Final push to forge UN treaty on plastic pollution set to begin in Busan
  1. 6

    Korea to hold own memorial for forced labor victims, boycotting Japan’s

    Korea to hold own memorial for forced labor victims, boycotting Japan’s
  2. 7

    Nvidia CEO signals Samsung’s imminent shipment of AI chips

    Nvidia CEO signals Samsung’s imminent shipment of AI chips
  3. 8

    Job creation lowest on record among under-30s

    Job creation lowest on record among under-30s
  4. 9

    NK troops disguised as 'indigenous' people in Far East for combat against Ukraine: report

    NK troops disguised as 'indigenous' people in Far East for combat against Ukraine: report
  5. 10

    Opposition leader awaits perjury trial ruling

    Opposition leader awaits perjury trial ruling
지나쌤

SK Bioscience inks W67b vaccine deal with Thailand's GPO

By Lee Yoon-seo

Published : Aug. 21, 2023 - 14:19

    • Link copied

From left: Opas Karnkawinpong, permanent secretary of the Ministry of Public Health in Thailand, Mingkwan Suphannaphong, managing director of GPO, Ahn Jae-yong, CEO of SK Bioscience, and Jeon Jo-young, charge d'affaires ad interim, Embassy of South Korea in Thailand, pose for a photo during a memorandum of understanding signing ceremony in Thailand on July 4. (SK Bioscience) From left: Opas Karnkawinpong, permanent secretary of the Ministry of Public Health in Thailand, Mingkwan Suphannaphong, managing director of GPO, Ahn Jae-yong, CEO of SK Bioscience, and Jeon Jo-young, charge d'affaires ad interim, Embassy of South Korea in Thailand, pose for a photo during a memorandum of understanding signing ceremony in Thailand on July 4. (SK Bioscience)

South Korean drugmaker SK Bioscience said via a regulatory filing Monday that it had clinched a 67.9 billion won ($50.6 million) deal with a Thai state-run company Government Pharmaceutical Organization to provide undiluted solutions of its flu vaccine for 10 years.

According to DART, the Financial Supervisory Service's electronic disclosure board, SK Bioscience will be providing undiluted solutions of its SKYCellflu products to GPO's vaccine manufacturing plant in Thailand until Aug. 18, 2033.

GPO will be in charge of the overall development and commercialization of SKYCellflu in Thailand, including applying for the marketing authorization from the Thai regulatory health agency. SK Bioscience said the influenza vaccine manufactured by GPO will aim to be used for Thailand's national immunization programs.

SK Bioscience added that the contract period and the amount of SKYCellflu supplied to GPO could change depending on the market situation, as the price was calculated based on an initially agreed minimum order.

SK Bioscience's recent supply contract deal comes as the Korean pharmaceutical company signed a memorandum of understanding with GPO on July 5, in a bid to strengthen exports of its products and provide support to Thailand in becoming a vaccine hub in Southeast Asia in the mid- to long-term.

The GPO is a state enterprise under the supervision of the Ministry of Public Health of Thailand established in 1966. Currently, Thailand's public hospitals are mandated to constitute at least 60 percent of its pharmaceuticals and medical devices as products from GPO.

More from Headlines